Diabetes Therapy to Improve BMI and Lung Function in CF
Completed
Cystic Fibrosis Foundation
Phase 3
2001-06-01
To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting
hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing
the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize
pulmonary function in cystic fibrosis (CF).
Diabetes Therapy to Improve BMI and Lung Function in CF
Completed
Cystic Fibrosis Foundation Therapeutics
Phase 3
2001-06-01
To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting
hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing
the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize
pulmonary function in cystic fibrosis (CF).
Diabetes Therapy to Improve BMI and Lung Function in CF
Completed
Novo Nordisk A/S
Phase 3
2001-06-01
To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting
hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing
the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize
pulmonary function in cystic fibrosis (CF).
Diabetes Therapy to Improve BMI and Lung Function in CF
Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3
2001-06-01
To recruit 150 adult patients with cystic fibrosis related diabetes (CFRD) without fasting
hyperglycemia for a multi-center, twelve month, placebo-controlled intervention trial testing
the ability of insulin or repaglinide to improve body mass index (BMI) and stabilize
pulmonary function in cystic fibrosis (CF).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
